Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant to Levobupivacaine in Vitreoretinal Surgery
NCT02327156Phase 3Completed
- Sponsor
- Magrabi Hospitals & Centers
- Start
- Jan 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dexmedetomidine, sponsored by Magrabi Hospitals & Centers. Started Jan 2014; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT02327156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327156.